908 DevicesMASS +2.87%70 Days Payable is 28.09 as of Mar. 2026, which is 23% above its 10-year median of 22.77. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.92 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 795 Medical Devices & Instruments companies, 908 Devices ranks worse than 80.25% on this metric.
The historical rank and industry rank for 908 Devices's Days Payable or its related term are showing as below:
MASS'
s Days Payable Range Over the Past 10 Years
Min: 18.96 Med: 22.77 Max: 34.48
Current: 34.48
During the past 8 years, 908 Devices's highest Days Payable was 34.48. The lowest was 18.96. And the median was 22.77.
MASS's Days Payable is ranked worse than 80.25% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs MASS: 34.48
908 Devices's Days Payable
declined
from Mar. 2025 (38.15) to Mar. 2026 (28.09).
It may suggest that 908 Devicesaccelerated paying its suppliers.
908 Devices Days Payable Related Terms
908 Devices Days Payable Historical Data
* Premium members only.
The historical data trend for 908 Devices's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 908 Devices's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Days Payable distribution charts can be found below:
* The bar in red indicates where 908 Devices's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
908 Devices's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
908 Devices (MASS) has a Days Payable of 28.09 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 908 Devices and its competitors. This is 23% above median its historical median of 22.77. Over the past decade, 908 Devices' Days Payable has ranged from 18.96 to 34.48. According to the industry distribution chart, 908 Devices ranks #638 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 80.3%.
Is 908 Devices' Days Payable too high?
908 Devices' current Days Payable of 28.09 is 23% above median its 10-year median of 22.77. Over the past 10 years, this metric has ranged from a low of 18.96 to a high of 34.48. The Medical Devices & Instruments industry median Days Payable is 67.87. 908 Devices' value of 28.09 is 58.6% below this industry median. Based on the distribution chart, 908 Devices ranks #638 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' Days Payable compare to ELMD and SI?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #638 out of 795 companies for Days Payable. This places 908 Devices in the lower half of its industry. The industry median Days Payable is 67.87. 908 Devices' value of 28.09 is 58.6% below this benchmark. Historically, 908 Devices' own Days Payable has ranged from 18.96 to 34.48 over the past decade. While the company's 10-year median is 22.77 vs. the industry median of 67.87, 908 Devices has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 908 Devices's current Days Payable of 28.09 is 58.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current Days Payable is 28.09, which is 23% above median its own 10-year median of 22.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.92, compared to a current price of $8.98 — trading 29.8% above its estimated fair value. The current Days Payable is 28.09, which is 23% above median its 10-year median of 22.77 and 58.6% below the Medical Devices & Instruments industry median of 67.87. 908 Devices' overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For 908 Devices (MASS), the current Days Payable is 28.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $8.98 is trading 29.8% above its estimated GF Value™ of $6.92.
GuruFocus considers 908 Devices to be Modestly Overvalued.
Key valuation signals for MASS:
Days Payable: 28.09 (23% above median its 10-year median of 22.77)
GF Value™: $6.92 vs. price of $8.98 (29.8% above fair value)
Industry Position: 58.6% below the Medical Devices & Instruments median (#638 of 795)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score
Get the complete analysis for MASS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
